As of December 2024, BrightPath Biotherapeutics has a market cap of $19.23M. This makes BrightPath Biotherapeutics the world's 28604th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $27.42M | -22.99% |
2023 | $35.60M | -13.00% |
2022 | $40.92M | -10.71% |
2021 | $45.83M | -38.46% |
2020 | $74.47M | -41.85% |
2019 | $128.08M | 49.05% |
2018 | $85.93M | -66.98% |
2017 | $260.25M | -8.36% |
2016 | $283.98M | 162.88% |
2015 | $108.03M | - |